Promoted by the Parijat Enterprises, Kopran is currently an integrated health care company. Kopran has used research-based technology to contribute towards total health-care. From diagnostics to treatment From Active Pharmaceutical Ingredients to Finished Dosage Forms From bio-technology to sophisticated Medical electronic equipments maintaining quality on par with the best in the world, and thereby vying for brand equity in the global context. The company started modestly as a Semi Synthetic Penicillin (SSP) player and expanded to becomes the largest SSP Player in India with an annual SSP facility of over 1200 tones per annum. Subsequently the SSP business was hived off into a separate Company in a joint venture with Synpac Pharmaceuticals Ltd, UK. Its future strategy is to focus on : Brand Equity Development Research for New Chemical Entities Globalise its operations thus making Kopran a truly International Pharmaceutical Company.